Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Sep 13;22(1):732.
doi: 10.1186/s12879-022-07711-w.

Depression management and antiretroviral treatment outcome among people living with HIV in Northwest and East regions of Cameroon

Affiliations
Randomized Controlled Trial

Depression management and antiretroviral treatment outcome among people living with HIV in Northwest and East regions of Cameroon

Jackson Jr Nforbewing Ndenkeh et al. BMC Infect Dis. .

Abstract

Background: Several interventions have shown benefits in improving mental health problems such as depression which is common in people living with HIV. However, there is a paucity of evidence on the effect of these interventions in improving HIV treatment outcomes. This study aimed at bridging this evidence gap and guiding the integration of depression and HIV management, particularly in rural health settings of Cameroon.

Materials and methods: We carried out a cluster-randomized intervention study targeting persons aged 13 years and above who had been on antiretroviral treatment for 6-9 months. Participants were followed up for 12 months during which those in the intervention group underwent routine screening and management of depression. Comparisons were done using the two-way ANOVA and Chi-squared test with significance set at 5%.

Results: Overall, 370 participants with a median age of 39 years (IQR: 30-49) were enrolled in this study. Of these, 42 (11.3%) were screened with moderate to severe depressive symptoms and 41 (11.1%) had poor treatment adherence. There was a significant drop in depression scores in the intervention group from 3.88 (± 3.76) to 2.29 (± 2.39) versus 4.35 (± 4.64) to 3.39 (± 3.0) in controls (p < 0.001) which was accompanied by a drop in the prevalence of moderate to severe depressive symptoms in the intervention group from 9% to 0.8% (p = 0.046). Decreased depression scores were correlated with better adherence scores with correlation coefficients of - 0.191, - 0.555, and - 0.513 at baseline, 6 months, and 12 months of follow-up respectively (p < 0.001) but there was no significant difference in adherence levels (p = 0.255) and viral suppression rates (p = 0.811) between groups.

Conclusion: The results of this study suggest that considering routine screening and management of depression as an integral component of HIV care could positively impact HIV treatment outcomes. However, there is a need for more research to identify the best combinations of context-specific and cost-effective strategies that can impactfully be integrated with HIV management. Trial registration Trial registration Number: DRKS00027440. Name of Registry: German Clinical Trials Register. Date registration: December 10, 2021 ('retrospectively registered'). Date of enrolment of the first participant: 05/08/2019.

Keywords: Adherence; Cameroon; Depression; HIV treatment outcomes; Interpersonal psychotherapy; Psychoeducation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig. 1
Fig. 1
Enrolment and follow up flowchart of study participants
Fig. 2
Fig. 2
Effect of intervention on depression over time (left: all study participants, right: participants with depressive symptoms in study)
Fig. 3
Fig. 3
Effect of intervention on treatment adherence over time (left: all study participants, right: participants with depressive symptoms in study)
Fig. 4
Fig. 4
Effect of intervention on viral load suppression at 12 months of follow-up (A all study participants, B participants with depressive symptoms in study)

References

    1. Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2012;2012:574656. - PMC - PubMed
    1. UNAIDS. Global HIV & AIDS statistics—fact sheet. 2021. https://aidsinfo.unaids.org/.
    1. UNAIDS. Cameroon HIV & AIDS statistics—fact sheet. 2021. https://aidsinfo.unaids.org/.
    1. Fokam J, Billong SC, Jogue F, MoyoTetangNdiang S, Nga Motaze AC, Paul KN, et al. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaounde-Cameroon. PLoS ONE. 2017;12(11):e0187566. doi: 10.1371/journal.pone.0187566. - DOI - PMC - PubMed
    1. Fokam J, Sosso SM, Yagai B, Billong SC, Djubgang Mbadie RE, Kamgaing Simo R, et al. Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”. AIDS Res Ther. 2019;16(1):36. doi: 10.1186/s12981-019-0252-0. - DOI - PMC - PubMed

Publication types

Substances

Associated data